10 August 2023
ECO Animal Health Group plc ("the Company")
(AIM: EAH)
Annual General Meeting
ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, is pleased to announce that the Company is today posting to shareholders notice of the Company's Annual General Meeting ("AGM") to be held at The Grange, 100 High Street, London, N14 6BN on Thursday 7 September 2023 at 2:30pm and Form of Proxy.
A copy of the notice of AGM and Form of Proxy will be available from the Company's website
www.ecoanimalhealthgroupplc.com/investor-relations.aspx
Contacts
|
ECO Animal Health Group plc David Hallas (Chief Executive Officer) Christopher Wilks (Chief Financial Officer)
|
|
| IFC Advisory Graham Herring Zach Cohen
| 020 3934 6630
|
| Singer Capital Markets (Nominated Adviser & Joint Broker) Philip Davies George Tzimas Sam Butcher
|
020 7496 3000 |
| Investec (Joint Broker) Gary Clarence Carlo Spingardi Lydia Zychowska
|
020 7597 5970
|
| Equity Development Hannah Crowe Matt Evans | 020 7065 2692 |
About ECO Animal Health
ECO Animal Health Group plc ("ECO" or "the "GROUP") researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.